Literature DB >> 7930672

Immunolocalization of collagenase and TIMP in healing human burn wounds.

G P Stricklin1, L B Nanney.   

Abstract

Degradative events in remodeling connective tissues are mediated through the actions of one or more members of the matrix metalloproteinase family. Conversely, members of the tissue inhibitors of metalloproteinase (TIMP) family act to attenuate proteolysis. Because collagenase and TIMP are rapidly secreted into the extracellular matrix following their biosynthesis and may not remain near their cell of origin, we undertook an immunohistochemical examination of human burn injuries to establish the distribution of these proteins during acute wound repair. Immunostaining for collagenase and TIMP was markedly increased within the wound bed but not in adjacent regions of histologically normal skin. Immunoreactive collagenase was first noted at the eschar-dermal interface by day 3 after injury and became very prominent in the dermis from day 5 to day 17. By day 5, focal patches of immunoreactive collagenase were found at the epidermal-dermal junctions at the wound margins. Within the wound bed, intense staining for collagenase was noted in the connective tissue surrounding the surviving epithelial appendages and around blood vessels. Immunoreactive TIMP was detected by day 2 both in the dermis and the overlying eschar but rapidly assumed the same interfacial pattern as described for collagenase. Staining for TIMP was only sporadically found at the dermal-epidermal margins and surrounding surviving epithelial appendages. Like collagenase, TIMP was prominently localized about vascular structures. These studies demonstrate that, in acute wounds, immunoreactive collagenase and TIMP are generally increased throughout the area of injury but particularly so at interface zones including eschar-dermis, epidermis-dermis, appendages-dermis, and around vascular structures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930672     DOI: 10.1111/1523-1747.ep12395601

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  Delayed wound healing in CXCR2 knockout mice.

Authors:  R M Devalaraja; L B Nanney; J Du; Q Qian; Y Yu; M N Devalaraja; A Richmond
Journal:  J Invest Dermatol       Date:  2000-08       Impact factor: 8.551

2.  Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone.

Authors:  S Bord; A Horner; R M Hembry; J J Reynolds; J E Compston
Journal:  J Anat       Date:  1997-07       Impact factor: 2.610

Review 3.  Noninvasive assessment of burn wound severity using optical technology: a review of current and future modalities.

Authors:  Meghann Kaiser; Amr Yafi; Marianne Cinat; Bernard Choi; Anthony J Durkin
Journal:  Burns       Date:  2010-12-23       Impact factor: 2.744

4.  Interleukin-1alpha-induced proteolytic activation of metalloproteinase-9 by human skin.

Authors:  Yuan-Ping Han; Susan Downey; Warren L Garner
Journal:  Surgery       Date:  2005-11       Impact factor: 3.982

5.  Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.

Authors:  T Hayashi; W G Stetler-Stevenson; M V Fleming; N Fishback; M N Koss; L A Liotta; V J Ferrans; W D Travis
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

6.  Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1.

Authors:  M La Fleur; J L Underwood; D A Rappolee; Z Werb
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

7.  Superficial Burn Wound Healing with Intermittent Negative Pressure Wound Therapy Under Limited Access and Conventional Dressings.

Authors:  Thittamaranahalli Muguregowda Honnegowda; Echalasara Govindarama Padmanabha Udupa; Pragna Rao; Pramod Kumar; Rekha Singh
Journal:  World J Plast Surg       Date:  2016-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.